Skip to content
MarketScale
‹ Back to IndustriesHealthcare

What Should Building Managers Do If COVID Doesn’t Go Away?

We all want the coronavirus to go away and for COVID-19, social distancing and everything that goes with it to be remembered as a horrible part of a weird year. There are some encouraging signs, with Pfizer announcing promising news about a vaccine candidate and other medical companies making progress. But what if the…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share
What Should Building Managers Do If COVID Doesn’t Go Away?

Get featured

Want to get featured in MarketScale Healthcare?

Create a free MarketScale workspace and get your company's expertise featured across our Healthcare coverage. No credit card, no demo required.

Request an invite

We all want the coronavirus to go away and for COVID-19, social distancing and everything that goes with it to be remembered as a horrible part of a weird year.

There are some encouraging signs, with Pfizer announcing promising news about a vaccine candidate and other medical companies making progress. But what if the vaccine isn’t effective, the virus mutates or it returns in different forms, like the flu?

Those possibilities are why everyone, but especially building managers, must ask the question of what we do if COVID doesn’t go away, said John Shanahan, President of Ionogen.

“Maybe it’s a mutation or maybe the flu gets smarter. We have to have more long-term strategies for getting people back into business,” Shanahan said.

Shanahan has found his company’s hypochlorous solutions highly effective in Ionogen’s own office, with none of his team of 50 testing positive for COVID during the pandemic.

“In February, when this really started to ramp up, we deployed all the humidification devices in our building. Because we made surface sanitizers and disinfectants and they were still trying to figure out what COVID was, we put the air sanitizers up as a preventative measure,” he said. “We were so busy February, March, April and May that there was no stopping. But because we have both the physical staff in our manufacturing division and we needed to be able to collaborate, we just added more units into our space.”

Now, they’re looking into the positive results of hypochlorous actually getting into the upper respiratory areas and potentially killing the virus.

“We’re very excited about the future of where this is going to take us. We will continue, as always, to do more testing and trials and the continued research on this,” Shanahan said. “We’re committed to science, and we like proof. Anecdotes are great, and we’ve got a lot of anecdotes about how this has worked up until now. Now, we’ll continue to dig down into the science. Hypochlorous could very well be the antidote without having to take the immunization.”

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Get your team featuredSee how it works15 minutes, straight to a calendar.

Follow Healthcare Insights

Get new expert content in your inbox.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

Two Radiology Deals Signal Focus on Coverage, Not Scanners

Two Radiology Deals Signal Focus on Coverage, Not Scanners

Colorado Imaging Associates and TRA Medical Imaging announced Sept. 8, 2026 that they are forming Affiliated Radiology to expand physician coverage for a shared health system client, Radiology Business reported. Separately, Align Capital Partners said in late May 2026 it agreed to acquire Boise-based Heritage Imaging, a mobile diagnostic imaging provider operating in 14 states, according to Radiology Business.

  • 01Affiliated Radiology was formed by combining Colorado Imaging Associates and TRA Medical Imaging to expand physician coverage for a shared health system client.
  • 02Heritage Imaging operates mobile diagnostic units across 14 states, providing PET-CT, MRI, nuclear medicine, ultrasound and echocardiography to critical access hospitals and community clinics.
  • 03Health system sourcing teams should request service-level commitments, credentialing procedures, cross-location read routing, and PACS/RIS/EHR integration details before contracting with coverage-focused or mobile imaging arrangements.

Sep 12, 2026

Dr. Sotirios Stathakis: A TheraPanacea Customer Interview

Dr. Sotirios Stathakis: A TheraPanacea Customer Interview

Dr. Sotirios Stathakis, Chief of Physics at Mary Bird Perkins Cancer Center, discusses how the facility integrated TheraPanacea's AI tools including MRI Box and Annotate to streamline workflows and improve treatment planning. The implementation, which began in 2023, demonstrates how thoughtful AI adoption enhances quality assurance and operational efficiency in cancer care.

  • 01MRI-only workflow adoption via MRI Box reduces need for CT scans, particularly for prostate and bladder cancer treatment
  • 02Annotate tool used in 40-45% of cases for head, neck, and abdominal procedures, offering precision beyond manual contouring
  • 03AI implementation strategy: start with control cases, build team confidence, then gradually expand to ensure smooth adoption and staff acceptance

Sep 11, 2026

Dr. Dana Rosencranz - Cancer Survivor and Chief Medical Physicist

Dr. Dana Rosencranz - Cancer Survivor and Chief Medical Physicist

Dr. Dana Rosencranz, Chief Medical Physicist at Texas Oncology, brings both professional expertise and personal experience as a breast cancer survivor to her role in advancing cancer care. Over 23 years at Texas Oncology, she champions technology adoption and AI integration in oncology while emphasizing the importance of human oversight in clinical applications.

  • 01Dr. Rosencranz is a five-year breast cancer survivor whose personal experience informs her approach to patient empathy and personalized care delivery.
  • 02AI applications in oncology like auto-contouring and treatment planning show significant advancement potential, but require consistent human leadership and oversight.
  • 03Texas Oncology reaches many demographics, including rural areas where travel to urban centers is hard, while staying current with the highest technology available.

Sep 11, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512